PDF(Pubmed)
Abstract：
BACKGROUND: Pharmacists provide a spectrum of services and comprehensive medication management for patients with substance use disorders (SUDs) with many providing timely and increased access to care for patients. Prior studies have evaluated other healthcare professionals\' attitudes, knowledge and practice in regard to SUD treatment and harm reduction services. However, no reviews to date summarise the available literature on the attitudes, knowledge and practice in regard to SUD treatment and harm reduction services from the pharmacist perspective. This scoping review aims to systematically map the extent, range and nature of available evidence and identify and describe gaps in knowledge, practice and attitudes towards SUD treatment among pharmacists with the goal of providing information for meaningful integration of pharmacists into SUD care.
METHODS: We will use the framework proposed by Arksey and O\'Malley (2005) updated with recommendations by Levac et al (2010) and the Joanna Briggs Institute (2020). The protocol is registered via Open Science Framework (https://osf.io/92dek). We will search for peer-reviewed literature containing empirical evidence investigating SUD treatment or harm reduction with outcomes pertaining to the knowledge, practice or attitudes of pharmacists. Findings will be guided and assessed by research objectives and summarised using descriptive statistics and thematically for quantitative and qualitative findings, respectively. This review will be conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews.
BACKGROUND: Our findings will provide crucial information and support for future interventions and programmes which aim to meaningfully integrate pharmacists into SUD care. We will disseminate findings at conferences and publish in a peer-reviewed journal. In addition, we will integrate feedback on search strategy, data extraction and our dissemination approach from multidisciplinary collaborators including those within our team\'s institution and outside experts with clinical or administrative knowledge in SUD care.
METHODS: We will use the framework proposed by Arksey and O\'Malley (2005) updated with recommendations by Levac et al (2010) and the Joanna Briggs Institute (2020). The protocol is registered via Open Science Framework (https://osf.io/92dek). We will search for peer-reviewed literature containing empirical evidence investigating SUD treatment or harm reduction with outcomes pertaining to the knowledge, practice or attitudes of pharmacists. Findings will be guided and assessed by research objectives and summarised using descriptive statistics and thematically for quantitative and qualitative findings, respectively. This review will be conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews.
BACKGROUND: Our findings will provide crucial information and support for future interventions and programmes which aim to meaningfully integrate pharmacists into SUD care. We will disseminate findings at conferences and publish in a peer-reviewed journal. In addition, we will integrate feedback on search strategy, data extraction and our dissemination approach from multidisciplinary collaborators including those within our team\'s institution and outside experts with clinical or administrative knowledge in SUD care.
摘要：
背景：药剂师为患有物质使用障碍（SUD）的患者提供一系列服务和全面的药物管理，其中许多为患者提供及时和更多的护理。先前的研究已经评估了其他医疗保健专业人员的态度，关于SUD治疗和减少伤害服务的知识和实践。然而,到目前为止，还没有评论总结有关态度的现有文献，从药剂师的角度来看，关于SUD治疗和减少伤害服务的知识和实践。这项范围审查旨在系统地绘制范围，现有证据的范围和性质，并识别和描述知识差距，药剂师对SUD治疗的实践和态度，目的是为药剂师有意义地融入SUD护理提供信息。
方法：我们将使用Arksey和O\'Malley（2005）提出的框架，并更新了Levac等人（2010）和JoannaBriggsInstitute（2020）的建议。该协议通过开放科学框架(https://osf.io/92dek)注册。我们将寻找同行评审的文献，其中包含研究SUD治疗或减少伤害的经验证据，药剂师的实践或态度。研究结果将根据研究目标进行指导和评估，并使用描述性统计数据和定量和定性研究结果的主题进行总结。分别。本审查将根据系统审查的首选报告项目和范围审查的荟萃分析进行和报告。
背景：我们的发现将为未来的干预措施和计划提供重要的信息和支持，这些干预措施和计划旨在将药剂师有意义地整合到SUD护理中。我们将在会议上传播调查结果，并在同行评审的期刊上发表。此外,我们将整合有关搜索策略的反馈，数据提取和我们的传播方法来自多学科合作者，包括我们团队机构内的合作者和具有SUD护理临床或管理知识的外部专家。
方法：我们将使用Arksey和O\'Malley（2005）提出的框架，并更新了Levac等人（2010）和JoannaBriggsInstitute（2020）的建议。该协议通过开放科学框架(https://osf.io/92dek)注册。我们将寻找同行评审的文献，其中包含研究SUD治疗或减少伤害的经验证据，药剂师的实践或态度。研究结果将根据研究目标进行指导和评估，并使用描述性统计数据和定量和定性研究结果的主题进行总结。分别。本审查将根据系统审查的首选报告项目和范围审查的荟萃分析进行和报告。
背景：我们的发现将为未来的干预措施和计划提供重要的信息和支持，这些干预措施和计划旨在将药剂师有意义地整合到SUD护理中。我们将在会议上传播调查结果，并在同行评审的期刊上发表。此外,我们将整合有关搜索策略的反馈，数据提取和我们的传播方法来自多学科合作者，包括我们团队机构内的合作者和具有SUD护理临床或管理知识的外部专家。
